TOJA, ANDREA
TOJA, ANDREA
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions
2024 Wojdała, Anna Lidia; Bellomo, Giovanni; Toja, Andrea; Gaetani, Lorenzo; Parnetti, Lucilla; Chiasserini, Davide
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers
2019 Farotti, L.; Sepe, F. N.; Toja, A.; Rinaldi, R.; Parnetti, L.
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts
2024 Bellomo, Giovanni; Bayoumy, Sherif; Megaro, Alfredo; Toja, Andrea; Nardi, Giovanna; Gaetani, Lorenzo; Blujdea, Elena R.; PAOLINI PAOLETTI, Federico; Lidia Wojdaƚa, Anna; Chiasserini, Davide; van der Flier, Wiesje M.; Verberk, Inge M. W.; Teunissen, Charlotte; Parnetti, Lucilla
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay
2024 Bellomo, Giovanni; Toja, Andrea; PAOLINI PAOLETTI, Federico; Ma, Yihua; Farris, Carly M.; Gaetani, Lorenzo; Salvadori, Nicola; Chiasserini, Davide; Lidia Wojdaƚa, Anna; Concha-Marambio, Luis; Parnetti, Lucilla
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum
2023 Paciotti, Silvia; Wojdała, Anna Lidia; Bellomo, Giovanni; Toja, Andrea; Chipi, Elena; Piersma, Sander R; Pham, Thang V; Gaetani, Lorenzo; Jimenez, Connie R; Parnetti, Lucilla; Chiasserini, Davide
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP
2023 Wojdała, Anna Lidia; Bellomo, Giovanni; Gaetani, Lorenzo; Toja, Andrea; Chipi, Elena; Shan, Dandan; Chiasserini, Davide; Parnetti, Lucilla
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions | 2024 | Wojdała, Anna Lidia; Bellomo, Giovanni; Toja, Andrea; Gaetani, Lorenzo; Parnetti, Lucilla; Chiasserini, Davide | |
| Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers | 2019 | Farotti, L.; Sepe, F. N.; Toja, A.; Rinaldi, R.; Parnetti, L. | |
| Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts | 2024 | Bellomo, Giovanni; Bayoumy, Sherif; Megaro, Alfredo; Toja, Andrea; Nardi, Giovanna; Gaetani, Lorenzo; Blujdea, Elena R.; PAOLINI PAOLETTI, Federico; Lidia Wojdaƚa, Anna; Chiasserini, Davide; van der Flier, Wiesje M.; Verberk, Inge M. W.; Teunissen, Charlotte; Parnetti, Lucilla | |
| Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay | 2024 | Bellomo, Giovanni; Toja, Andrea; PAOLINI PAOLETTI, Federico; Ma, Yihua; Farris, Carly M.; Gaetani, Lorenzo; Salvadori, Nicola; Chiasserini, Davide; Lidia Wojdaƚa, Anna; Concha-Marambio, Luis; Parnetti, Lucilla | |
| Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum | 2023 | Paciotti, Silvia; Wojdała, Anna Lidia; Bellomo, Giovanni; Toja, Andrea; Chipi, Elena; Piersma, Sander R; Pham, Thang V; Gaetani, Lorenzo; Jimenez, Connie R; Parnetti, Lucilla; Chiasserini, Davide | |
| Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP | 2023 | Wojdała, Anna Lidia; Bellomo, Giovanni; Gaetani, Lorenzo; Toja, Andrea; Chipi, Elena; Shan, Dandan; Chiasserini, Davide; Parnetti, Lucilla |